100 related articles for article (PubMed ID: 8828355)
1. [Changes in platelet sensitivity to thromboxane A2 in pediatric patients with nephrotic syndrome].
Watanabe M; Suzuki J; Suzuki H
Nihon Jinzo Gakkai Shi; 1996 Aug; 38(8):356-63. PubMed ID: 8828355
[TBL] [Abstract][Full Text] [Related]
2. Changes in platelet calcium concentration by thromboxane A2 stimulation in patients with nephrotic syndrome of childhood.
Kobayashi T; Suzuki J; Watanabe M; Suzuki S; Yoshida K; Kume K; Suzuki H
Nephron; 1997; 77(3):309-14. PubMed ID: 9375825
[TBL] [Abstract][Full Text] [Related]
3. Pathogenetic analysis of five cases with a platelet disorder characterized by the absence of thromboxane A2 (TXA2)-induced platelet aggregation in spite of normal TXA2 binding activity.
Fuse I; Hattori A; Mito M; Higuchi W; Yahata K; Shibata A; Aizawa Y
Thromb Haemost; 1996 Dec; 76(6):1080-5. PubMed ID: 8972034
[TBL] [Abstract][Full Text] [Related]
4. Increased thromboxane metabolites excretion in liver cirrhosis.
Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
[TBL] [Abstract][Full Text] [Related]
5. [The effect of peripheral blood mononuclear cell products from children with nephrotic syndrome on thromboxane A2 metabolism].
Watanabe Y; Suzui J; Ichikawa Y; Yoshida K; Suzuki H
Arerugi; 1995 May; 44(5):547-55. PubMed ID: 7619008
[TBL] [Abstract][Full Text] [Related]
6. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
Bureau MF; De Clerck F; Lefort J; Arreto CD; Vargaftig BB
J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
Vezza R; Nenci GG; Gresele P
J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
[TBL] [Abstract][Full Text] [Related]
8. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
[TBL] [Abstract][Full Text] [Related]
9. Increased platelet thromboxane synthesis in diabetes mellitus.
Halushka PV; Rogers RC; Loadholt CB; Colwell JA
J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
[TBL] [Abstract][Full Text] [Related]
10. Increased thromboxane B2 excretion in diabetes mellitus.
Katayama S; Inaba M; Maruno Y; Omoto A; Kawazu S; Ishii J
J Lab Clin Med; 1987 Jun; 109(6):711-7. PubMed ID: 3585144
[TBL] [Abstract][Full Text] [Related]
11. Mutations of the platelet thromboxane A2 (TXA2) receptor in patients characterized by the absence of TXA2-induced platelet aggregation despite normal TXA2 binding activity.
Higuchi W; Fuse I; Hattori A; Aizawa Y
Thromb Haemost; 1999 Nov; 82(5):1528-31. PubMed ID: 10595649
[TBL] [Abstract][Full Text] [Related]
12. Increased thromboxane biosynthesis in essential thrombocythemia.
Rocca B; Ciabattoni G; Tartaglione R; Cortelazzo S; Barbui T; Patrono C; Landolfi R
Thromb Haemost; 1995 Nov; 74(5):1225-30. PubMed ID: 8607099
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity to thromboxane A2 in cholesterol-rich human platelets.
Tomizuka T; Yamamoto K; Hirai A; Tamura Y; Yoshida S
Thromb Haemost; 1990 Dec; 64(4):594-9. PubMed ID: 2150728
[TBL] [Abstract][Full Text] [Related]
14. Hemorrhagic thrombocytopathy with platelet thromboxane A2 receptor abnormality: defective signal transduction with normal binding activity.
Ushikubi F; Okuma M; Kanaji K; Sugiyama T; Ogorochi T; Narumiya S; Uchino H
Thromb Haemost; 1987 Apr; 57(2):158-64. PubMed ID: 2955539
[TBL] [Abstract][Full Text] [Related]
15. Ridogrel inhibits systemic and renal formation of thromboxane A2 and antagonizes platelet thromboxane A2/prostaglandin endoperoxide receptors upon chronic administration to man.
Weber C; Beetens JR; Tegtmeier F; Van Rooy P; Vercammen E; Wouters L; De Clerck F
Thromb Haemost; 1992 Aug; 68(2):214-20. PubMed ID: 1412169
[TBL] [Abstract][Full Text] [Related]
16. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
Robbins DL; Leung S; Miller-Blair DJ; Ziboh V
J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202
[TBL] [Abstract][Full Text] [Related]
17. The role of prostacyclin (PGI2) and thromboxane A2 (TXA2) in pathogenesis of dengue hemorrhagic fever (DHF).
Preeyasombat C; Treepongkaruna S; Sriphrapradang A; Choubtum L
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S16-21. PubMed ID: 10730512
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
DeFilippis AP; Oloyede OS; Andrikopoulou E; Saenger AK; Palachuvattil JM; Fasoro YA; Guallar E; Blumenthal RS; Kickler TS; Jaffe AS; Gerstenblith G; Schulman SP; Rade JJ
Circ J; 2013; 77(11):2786-92. PubMed ID: 23985963
[TBL] [Abstract][Full Text] [Related]
19. Castration reduces platelet thromboxane A2 receptor density and aggregability.
Ajayi AA; Halushka PV
QJM; 2005 May; 98(5):349-56. PubMed ID: 15820970
[TBL] [Abstract][Full Text] [Related]
20. [11-Dehydro-TXB2 and 2,3-dinor-TXB2 as new parameters of TXA2 generation].
Katori M; Kawamura M; Sawada M
Nihon Rinsho; 1992 Feb; 50(2):349-54. PubMed ID: 1613989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
